Upgrade to SI Premium - Free Trial

BiomX Inc. (PHGE)

0.21 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (3/27/24)

Latest Headlines

Form SC 13G/A BiomX Inc. Filed by: MMCAP International Inc. SPC February 13, 2024 1:09 PM - SEC Filing Form SC 13G/A BiomX Inc. Filed by: JOHNSON & JOHNSON February 2, 2024 5:08 PM - SEC Filing Form SC 13G/A BiomX Inc. Filed by: Cystic Fibrosis Foundation January 30, 2024 4:06 PM - SEC Filing BiomX Receives Orphan Drug Designation from the U.S. Food and Drug Administration for BX004 for the Treatment of Chronic Pulmonary Infection Caused by Pseudomonas aeruginosa in Patients with Cystic Fi January 4, 2024 8:00 AM - Globe NewsWire Form EFFECT BiomX Inc. January 3, 2024 6:03 AM - SEC Filing BiomX Inc. (PHGE) Files $150M Mixed Shelf December 28, 2023 4:09 PM - StreetInsider Form S-3/A BiomX Inc. December 28, 2023 4:06 PM - SEC Filing Form 4 BiomX Inc. For: Dec 11 Filed by: Wolfson Marina December 13, 2023 4:45 PM - SEC Filing Form 4 BiomX Inc. For: Dec 11 Filed by: Bassan Merav December 13, 2023 4:44 PM - SEC Filing Form 4 BiomX Inc. For: Dec 11 Filed by: Solomon Jonathan Eitan December 13, 2023 4:43 PM - SEC Filing Form 4 BiomX Inc. For: Dec 11 Filed by: Oron Assaf December 13, 2023 4:42 PM - SEC Filing Form SC TO-I/A BiomX Inc. Filed by: BiomX Inc. December 12, 2023 4:21 PM - SEC Filing Form 3 BiomX Inc. For: Dec 06 Filed by: Gabay Avraham December 11, 2023 4:46 PM - SEC Filing Form 8-K BiomX Inc. For: Dec 07 December 7, 2023 5:30 PM - SEC Filing Form S-3 BiomX Inc. December 7, 2023 5:04 PM - SEC Filing Form 8-K BiomX Inc. For: Dec 07 December 7, 2023 4:10 PM - SEC Filing Form 4 BiomX Inc. For: Nov 29 Filed by: Oron Assaf December 1, 2023 4:47 PM - SEC Filing BiomX to Host Virtual Key Opinion Leader (KOL) Event to Review the Positive Results from Part 2 of Phase 1b/2a Trial of BX004 in Cystic Fibrosis Patients with Chronic Pseudomonas aeruginosa Infections November 30, 2023 4:15 PM - Globe NewsWire Form 8-K BiomX Inc. For: Nov 29 November 29, 2023 6:38 AM - SEC Filing BiomX Announces Positive Topline Results from Part 2 of the Phase 1b/2a Trial Evaluating BX004 for Treatment of Chronic Pulmonary Infections in Patients with Cystic Fibrosis November 29, 2023 6:30 AM - Globe NewsWire Full Article List